DEFA14A ·Filed Apr 1, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Wait for the actual proxy statement content to be available to understand what is being voted on and assess potential impact
INSM drugs
INSM drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$162.43
T+0 close · Apr 1, 2026 · via day close
Latest settled
−34.36%
T+60 · $106.62
Vs SPY
−48.52%
α at T+60
Horizons
All settled
through T+60
- T+0 · Apr 2 $162.43entry
- T+1 · 8mo ago +0.85%α +0.37% · $163.81
- T+5 · 7mo ago −4.69%α −8.31% · $154.81
- T+20 · 7mo ago −16.07%α −25.95% · $136.33
- T+60 · 5mo ago −34.36%α −48.52% · $106.62
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable
Key Facts
- Filing type is DEFA14A, which is a definitive additional proxy statement
- No document content was provided to analyze the specific vote items or proposals
- This is a routine filing related to shareholder voting matters
Financial Impact
No financial impact can be determined from available information
Risk Factors
- Inability to determine voting implications without document content
- Potential for material proposals to be included that cannot be assessed
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104506-26-000023 |
| Document: 0001104506-26-000023-index-headers.html | 0001104506-26-000023 |
| Document: 0001104506-26-000023-index.html | 0001104506-26-000023 |
| Document: 0001104506-26-000023.txt | 0001104506-26-000023 |
Track record
24 reports on INSM
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
- Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
- Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
Showing 10 of 24
US Market Status
Market Closed · Opens Wed (10h 38m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers